Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Completed

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

NCT03041025

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +1 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Completed

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis

NCT03798366

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Pacific Arthritis Care Center Los Angeles, California, United States
  • UCLA Rheumatology Los Angeles, California, United States
  • RASF Clinical Research Center Boca Raton, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Completed

A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

NCT03675581

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +1 more
Locations
  • UNIV UZ Gent Ghent, Belgium
  • HOP Avicenne Bobigny, France
  • HOP Bichat Paris, France
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details

Related conditions